» Articles » PMID: 8351349

Proton MR and Human Cervical Neoplasia: Ex Vivo Spectroscopy Allows Distinction of Invasive Carcinoma of the Cervix from Carcinoma in Situ and Other Preinvasive Lesions

Overview
Journal Radiology
Specialty Radiology
Date 1993 Sep 1
PMID 8351349
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The concept that high-resolution (8.5-T) hydrogen-1 magnetic resonance (MR) spectroscopy can be used as an adjunct to conventional histologic diagnosis of cervical neoplasia was investigated. Cervical biopsy specimens (n = 159) were examined with H-1 MR spectroscopy and the results compared with results of histopathologic analysis. A high-resolution lipid MR spectrum was observed in 39 of 40 invasive carcinomas, whereas the 119 preinvasive samples showed little or no lipid spectrum but were characterized by a strong unresolved resonance between 3.8 and 4.2 ppm. Peak ratios of the methylene/methyl and the unresolved/methylene resonances allowed accurate distinction between invasive and preinvasive epithelial malignancy (P < .0001). Since MR spectroscopic examination does not destroy the specimen, the specimens remained intact for further testing and histopathologic analysis. The authors conclude that H-1 MR spectroscopy can independently allow distinction between invasive and preinvasive lesions of the cervix and has the potential to assist in clinical management of cervical cancer.

Citing Articles

H magnetic resonance spectroscopy in the differentiation between low- and high-grade cervical carcinoma: is it efficient?.

Ibrahim Amin M, Amin A, Badr S, Ebaid N Pol J Radiol. 2024; 89:e378-e385.

PMID: 39257922 PMC: 11384214. DOI: 10.5114/pjr/190840.


Utilization of functional MRI in the diagnosis and management of cervical cancer.

Matani H, Patel A, Horne Z, Beriwal S Front Oncol. 2022; 12:1030967.

PMID: 36439416 PMC: 9691646. DOI: 10.3389/fonc.2022.1030967.


The contribution of the H-MRS lipid signal to cervical cancer prognosis: a preliminary study.

Dolciami M, Canese R, Testa C, Pernazza A, Santangelo G, Palaia I Eur Radiol Exp. 2022; 6(1):47.

PMID: 36184731 PMC: 9527268. DOI: 10.1186/s41747-022-00300-1.


Proton magnetic resonance spectroscopy of lung cancer .

Fujimoto S, Minato K, Horikoshi H, Suga S, Sato M, Mashimo K Radiol Case Rep. 2020; 15(7):1099-1102.

PMID: 32489513 PMC: 7256246. DOI: 10.1016/j.radcr.2020.05.018.


Proton MRS of cervical cancer at 7 T.

Arteaga de Castro C, Hoogendam J, van Kalleveen I, Raaijmakers A, Zweemer R, Verheijen R NMR Biomed. 2018; 32(1):e4015.

PMID: 30376201 PMC: 6588007. DOI: 10.1002/nbm.4015.